GeNeuro Company
GeNeuro is a biotechnology company that develops therapeutic drugs for diseases associated with the expression of pathogenic proteins of the human endogenous retroviral origin.
The company is primarily focused on nervous system diseases such as multiple sclerosis and schizophrenia. Its products include GNbAC1, a therapeutic monoclonal antibody for the treatment of multiple sclerosis. It also develops diagnostic tests to dose the multiple sclerosis-associated retrovirus-ENV proteins in patients.GeNeuro was founded in 2006 and is based in Plan-Les-Ouates, Switzerland.
%20Switzerland.png)
Employee Number:
11-50
Headquarters:
Geneva, Geneve, Switzerland, Europe
Founded Date:
2006-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41227945085
Investors:
European Investment Bank, Federal Office of Public Health (FOPH) Switzerland, Institut Merieux, Invesco, Servier
Ipo Status:
public
Stock Symbol:
GNRO
City:
Geneva
Region:
Geneve
Country:
Switzerland
Founders:
Jesús Martin-Garcia